In summary, we show here that whole body disruption or liver specific disruption of the mTOR substrate S6K1 can increase survival and delay disease symptoms in a mouse model of severe mitochondrial disease. This evidence concerns the gene MTOR and inborn mitochondrial metabolism disorder.